JHS

JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories Limited (JHS) financial statements and selected valuation metrics through 30 June 2026.

Fast Moving Consumer Goods›Fast Moving Consumer Goods›Personal Products›Personal Care

svendgaard.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹9.02
Market cap
79 Cr
Stock P/E
Loss (TTM EPS ₹-0.19)
P/B
0.45
ROE (FY26)
-1.1%
ROCE (FY26)
-0.8%
Operating margin (FY26)
-4.8%
Debt / equity (FY26)
0.08

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

JHS Svendgaard Laboratories makes oral care products, and the company reports this as its one operating segment.

Company snapshot

10thBy market cap

Ranked among 10 companies in Personal Care.

Segment mix

Reportable segments as of 2023-06-30 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 77.6% of revenue

SegmentRevenue shareRevenuePBTAssets
Manufacturing Business
77.6%
15 Cr-2 Cr132 Cr
Other Than Manufacturing Business
6.7%
1 Cr-1 Cr54 Cr
Retail Business
16.4%
3 Cr-0.59 Cr9 Cr

What we see

Positives
  • ✓Debt-to-equity of 0.08x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 20251Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales19 Cr14 Cr22 Cr24 Cr20 Cr23 Cr25 Cr23 Cr22 Cr23 Cr33 Cr30 Cr
Operating expenses (approx.)19 Cr14 Cr21 Cr23 Cr21 Cr22 Cr31 Cr22 Cr21 Cr22 Cr34 Cr28 Cr
EBITDA0.41 Cr-0.06 Cr0.84 Cr2 Cr-0.85 Cr0.25 Cr-5 Cr2 Cr0.91 Cr2 Cr-2 Cr2 Cr
OPM %2.1%-0.4%3.9%8.0%-4.3%1.1%-21.4%7.1%4.1%7.2%-5.0%6.8%
Other income0.20 Cr2 Cr1 Cr0.32 Cr0.86 Cr0.27 Cr1 Cr1.00 Cr1 Cr0.59 Cr0.73 Cr0.09 Cr
Interest0.10 Cr0.11 Cr0.13 Cr0.12 Cr0.11 Cr0.13 Cr0.21 Cr0.16 Cr0.20 Cr0.28 Cr0.22 Cr0.28 Cr
Depreciation1 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Profit before tax-0.99 Cr0.55 Cr0.18 Cr0.20 Cr-2 Cr-2 Cr-9 Cr0.63 Cr-0.02 Cr0.08 Cr-3 Cr0.06 Cr
Tax %26.6%97.7%519.1%416.1%-397.8%-16.0%—-68.1%-1136.3%-888.6%-19.7%-1664.4%
Net profit-0.73 Cr0.01 Cr-0.75 Cr-0.63 Cr-10 Cr-2 Cr-7 Cr1 Cr-0.20 Cr0.79 Cr-4 Cr1 Cr
EPS (₹)₹-0.09₹0.00₹-0.10₹-0.08₹-1.24₹-0.21—₹0.12₹0.02₹0.09₹-0.42₹0.12
  1. 1Mar 2025: Derived from year-to-date: the year to 31 Mar 2025 less the quarters to 30 Jun 2024, 30 Sep 2024 and 31 Dec 2024; the filing gives no figures for this quarter alone

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales105 Cr143 Cr124 Cr139 Cr101 Cr86 Cr96 Cr71 Cr92 Cr102 CrSign in free for the trailing twelve months
Operating expenses (approx.)93 Cr129 Cr125 Cr137 Cr99 Cr87 Cr105 Cr72 Cr96 Cr99 CrSign in free for the trailing twelve months
EBITDA12 Cr14 Cr-0.59 Cr2 Cr2 Cr-0.84 Cr-9 Cr-0.94 Cr-4 Cr3 CrSign in free for the trailing twelve months
OPM %11.1%9.6%-0.5%1.2%1.9%-1.0%-9.5%-1.3%-4.4%2.6%Sign in free for the trailing twelve months
Other income0.43 Cr5 Cr7 Cr14 Cr8 Cr9 Cr14 Cr4 Cr3 Cr3 CrSign in free for the trailing twelve months
Interest0.62 Cr0.74 Cr1 Cr2 Cr1 Cr1 Cr1 Cr0.46 Cr0.56 Cr0.86 CrSign in free for the trailing twelve months
Depreciation6 Cr7 Cr7 Cr9 Cr7 Cr7 Cr7 Cr6 Cr8 Cr7 CrSign in free for the trailing twelve months
Profit before tax5 Cr38 Cr-2 Cr-6 Cr2 Cr0.10 Cr-22 Cr-3 Cr-13 Cr-2 CrSign in free for the trailing twelve months
Tax %-327.0%32.2%18.5%13.0%41.2%4264.5%23.2%-18.3%-57.5%16.1%Sign in free for the trailing twelve months
Net profit22 Cr26 Cr-2 Cr-5 Cr1 Cr-4 Cr-17 Cr-4 Cr-20 Cr-2 CrSign in free for the trailing twelve months
EPS (₹)₹5.45₹4.61₹-0.11₹-0.32₹0.20₹-0.63₹-1.52₹-0.52₹-2.37₹-0.22Sign in free for the trailing twelve months
Dividend payout %————0.0%—————Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital44 Cr61 Cr61 Cr61 Cr64 Cr65 Cr65 Cr78 Cr86 Cr87 Cr
Reserves90 Cr113 Cr116 Cr117 Cr124 Cr121 Cr108 Cr91 Cr87 Cr87 Cr
Borrowings0.74 Cr1 Cr6 Cr0.52 Cr0.47 Cr0.69 Cr0.38 Cr4 Cr5 Cr15 Cr
Other liabilities20 Cr33 Cr35 Cr56 Cr30 Cr26 Cr56 Cr24 Cr23 Cr26 Cr
Total liabilities155 Cr208 Cr221 Cr241 Cr228 Cr222 Cr236 Cr197 Cr201 Cr215 Cr
Fixed assets (net)65 Cr71 Cr70 Cr57 Cr58 Cr55 Cr63 Cr86 Cr86 Cr87 Cr
CWIP0.67 Cr0.51 Cr5 Cr7 Cr9 Cr20 Cr9 Cr0.82 Cr0 Cr4 Cr
Investments1 Cr18 Cr10 Cr13 Cr6 Cr2 Cr1 Cr3 Cr4 Cr5 Cr
Loans & advances——8 Cr4 Cr4 Cr15 Cr5 Cr0.02 Cr0 Cr0 Cr
Inventories11 Cr10 Cr9 Cr6 Cr12 Cr12 Cr14 Cr13 Cr12 Cr15 Cr
Trade receivables14 Cr43 Cr54 Cr96 Cr59 Cr18 Cr21 Cr13 Cr13 Cr17 Cr
Cash & bank6 Cr6 Cr0.81 Cr0.68 Cr21 Cr5 Cr38 Cr9 Cr7 Cr4 Cr
Other assets59 Cr60 Cr65 Cr57 Cr60 Cr94 Cr86 Cr73 Cr80 Cr84 Cr
Total assets155 Cr208 Cr221 Cr241 Cr228 Cr222 Cr236 Cr197 Cr201 Cr215 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-4 Cr14 Cr-11 Cr10 Cr12 Cr-9 Cr19 Cr-9 Cr-5 Cr-3 Cr
Cash from investing-3 Cr-27 Cr-7 Cr-11 Cr-2 Cr-5 Cr10 Cr-21 Cr-20 Cr-12 Cr
Cash from financing10 Cr14 Cr13 Cr0.49 Cr10 Cr-2 Cr10 Cr2 Cr23 Cr11 Cr
Net cash flow3 Cr0.42 Cr-5 Cr-0.13 Cr20 Cr-16 Cr39 Cr-28 Cr-2 Cr-3 Cr
Free cash flow (OCF − Capex)-17 Cr3 Cr-26 Cr0.08 Cr4 Cr-16 Cr19 Cr-33 Cr-15 Cr-15 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %4.3%22.3%-0.5%-2.0%1.8%0.8%-11.5%-1.7%-6.7%-0.8%
ROE %16.3%15.0%-0.4%-1.1%0.6%-2.1%-8.6%-2.4%-11.4%-1.1%
Debtor days471091582522127678665260
Inventory days644240226682891137585
Days payable83105103139919413812685100
Cash conversion cycle2846951351876529534245
OCF / EBITDA %-33.6%100.4%—n.m.n.m.————n.m.
OCF / EBITDA % (3 years)——-3.7%90.1%n.m.n.m.————
Debt / equity0.00550.00630.030.00290.00250.00370.00220.020.030.08
Current ratio2.163.242.632.695.234.182.361.872.181.95
Net debt / EBITDA-0.41——-0.10-10.59————4.23